a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1959 clinical trials
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)

In the last 5 years there has been remarkable progress in identifying genetic variants that affect risk of CAD, with much of this work being co-led from Leicester. These discoveries provide a framework for testing whether the addition of genetic information in the form of a genetic risk score can …

arteriopathy
coronary disease
cardiovascular disease
  • 0 views
  • 19 Feb, 2024
  • 1 location
Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2).

vascular endothelial growth factor receptor 2
metastasis
postoperative complication
growth factor
glioma
  • 0 views
  • 19 Feb, 2024
  • 1 location
HeartStart FRx Defibrillator Event Registry

This post market clinical follow-up study is a multi-center, non-randomized, unblinded, observational registry of the performance of the FRx Automated external defibrillator (AED) used in conjunction with electrodes with or without use of the infant/child key.

defibrillation
shock
circulatory arrest
  • 0 views
  • 19 Feb, 2024
  • 1 location
Spontaneous Coronary Artery Dissection National Swiss Registry

Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood. In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.

  • 0 views
  • 19 Feb, 2024
  • 1 location
DeBakey Cardiovascular Magnetic Resonance Study

The aim of this large prospective registry revolves around 4 key principles: 1) utilize CMR to gain additional pathophysiologic insights into cardiovascular disease, 2) understand how CMR compares to alternative cardiovascular diagnostic modalities, 3) determine how CMR affects clinical management decisions, and 4) establish a link between CMR findings and …

vascular disease
heart disease
cardiovascular disease
  • 0 views
  • 19 Feb, 2024
  • 1 location
French Observatory of ElectroConvulsive Therapy (ECT)

Since the 30s, ECT has been a psychiatric treatment mainly used for drug-resistant depressive illnesses. Clinical studies have shown its therapeutic efficiency compared to standard treatments also in other psychiatric illnesses.

psychiatric treatment
electroconvulsive treatment
psychiatric disorder
psychiatric care
  • 0 views
  • 19 Feb, 2024
  • 1 location
Mucopolysaccharidosis I (MPS I) Registry

The objectives of the Registry are: To evaluate the long-term effectiveness and safety of Aldurazyme (laronidase) To characterize and describe the MPS I population as a whole, including the variability, progression, and natural history of MPS I To help the MPS I medical community with the development of recommendations for …

  • 0 views
  • 19 Feb, 2024
  • 136 locations
Pompe Disease Registry

The objectives of the Registry are: To enhance the understanding of the variability, progression, and natural history of the key manifestations of Pompe disease; To assist the Pompe medical community with the development of recommendations for monitoring patients and reports on patient outcomes to help optimize patient care; To characterize …

myozyme
glycogen storage disease type ii
replacement therapy
deficiency
gaa gene
  • 0 views
  • 19 Feb, 2024
  • 191 locations
French COVID Cohort

Even for known infections, resistance to antimicrobial therapies is widespread, and treatments to control potentially deleterious host responses are lacking. In order to develop a mechanistic understanding of disease processes, such that risk factors for severe illness can be identified and treatments can be developed, it is necessary to understand …

SARS
coronavirus infection
middle east respiratory syndrome
influenza
antibiotics
  • 0 views
  • 19 Feb, 2024
  • 81 locations
LIPAD - LRRK2 International Parkinson's Disease Study

We therefore aim to identify 4,000 people internationally, of them 1,500 with LRRK2-associated Parkinson's syndrome, 500 with LRRK2-mutations but without Parkinson's symptoms, 500 without mutations and without Parkinson's symptoms, 500 Parkinson patients with mutations in other genes than LRRK2 and 1,000 patients with idiopathic Parkinson's disease from the same populations. …

  • 0 views
  • 19 Feb, 2024
  • 1 location